Who owns Neurogene Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NGNE from SEC Form 13F filings across 111 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 111 institutions disclosed 17.3M shares of Neurogene Inc. worth $544.4M — about 76.8% of shares outstanding; the largest disclosed holder is SAMSARA BIOCAPITAL, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
111
13F holders
$544.4M
value, 2026 filers
76.8%
of shares outstanding (17.3M sh)
21
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of NGNE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | SAMSARA BIOCAPITAL, LLC | 1.7M | $54.0M | 4.4% | 7.6% | 0.0% |
| 2 | Casdin Capital, LLC | 1.5M | $48.6M | 2.4% | 6.9% | +8.8% |
| 3 | Redmile Group, LLC | 1.4M | $44.4M | 3.0% | 6.3% | -3.2% |
| 4 | RTW INVESTMENTS, LP | 1.4M | $42.8M | 0.4% | 6% | 0.0% |
| 5 | EcoR1 Capital, LLC | 1.3M | $40.0M | 1.9% | 5.6% | 0.0% |
| 6 | BlackRock, Inc. | 1.1M | $33.3M | 0.0% | 4.7% | +5.3% |
| 7 | BAKER BROS. ADVISORS LP | 991,691 | $31.2M | 0.2% | 4.4% | 0.0% |
| 8 | Balyasny Asset Management L.P. | 818,706 | $25.7M | 0.0% | 3.6% | +14.0% |
| 9 | Trails Edge Capital Partners, LP | 714,885 | $22.5M | 3.6% | 3.2% | -8.7% |
| 10 | TORONTO DOMINION BANK | 681,337 | $21.4M | 0.0% | 3% | 0.0% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 536,525 | $16.9M | 0.0% | 2.4% | +4.2% |
| 12 | JENNISON ASSOCIATES LLC | 518,582 | $16.3M | 0.0% | 2.3% | -1.7% |
| 13 | CITADEL ADVISORS LLC | 408,982 | $12.9M | 0.0% | 1.8% | +5.7% |
| 14 | GREAT POINT PARTNERS LLC | 352,180 | $11.1M | 2.1% | 1.6% | -29.6% |
| 15 | ArrowMark Colorado Holdings LLC | 342,453 | $10.8M | 0.4% | 1.5% | -34.7% |
| 16 | FMR LLC | 295,561 | $9.3M | 0.0% | 1.3% | -22.8% |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 293,182 | $9.2M | 0.0% | 1.3% | +5.1% |
| 18 | STATE STREET CORP | 224,322 | $7.1M | 0.0% | 1% | -28.3% |
| 19 | FRANKLIN RESOURCES INCNEW | 204,280 | $6.4M | 0.0% | 0.9% | new |
| 20 | MORGAN STANLEY | 191,724 | $6.0M | 0.0% | 0.9% | -32.8% |
| 21 | UBS Group AG | 171,289 | $5.4M | 0.0% | 0.8% | -7.7% |
| 22 | BLAIR WILLIAM & CO/IL | 146,905 | $4.6M | 0.0% | 0.7% | -12.7% |
| 23 | Driehaus Capital Management LLC | 143,528 | $4.5M | 0.0% | 0.6% | +338.1% |
| 24 | Point72 Asset Management, L.P.NEW | 141,920 | $4.5M | 0.0% | 0.6% | new |
| 25 | MOORE CAPITAL MANAGEMENT, LPNEW | 141,636 | $4.5M | 0.1% | 0.6% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.